Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics publishing date : 2021 - 09 - 20 save search
PTC Therapeutics to Host Conference Call to Discuss Results of PTC518 Phase 1 Study for Huntington's Disease Program
Published: 2021-09-20 (Crawled : 21:00) - prnewswire.com
PTCT | News S | $25.19 -0.87% -0.87% 560K
|
Health Technology
|
| O: 0.26%
H: 5.28%
C: 4.48%
huntington disease phase 1 results conference phase 2 huntington’s disease
Aprea Therapeutics Presents Data From Phase 1/2 Trial of Eprenetapopt (APR-246) in Advanced Solid Tumors at ESMO Congress 2021
Published: 2021-09-20 (Crawled : 21:00) - globenewswire.com
APRE | $5.37 6.3% 6.3K
|
Health Technology
|
| O: 1.86%
H: 2.23%
C: -5.47%
solid tumors phase 1 trial
Viridian Therapeutics Announces Proposed Underwritten Public Offering of Common Stock and Preferred Stock
Published: 2021-09-20 (Crawled : 20:00) - globenewswire.com
VRDN | $13.04 -8.49% -9.28% 770K
|
Health Care and Social Assistan...
|
| O: 10.63%
H: 10.85%
C: 0.56%
offering
584MP, Contracts Administrator
Published: 2021-09-20 (Crawled : 20:00) - fatetherapeutics.com
FATE | News | $4.3 -5.29% -5.58% 2M
|
Health Technology
|
| O: 0.71%
H: 4.82%
C: 0.66%
contract
Alterity Announces Presentation of Biomarker Data at the International Parkinson and Movement Disorder Society Congress 2021
Published: 2021-09-20 (Crawled : 15:00) - prnewswire.com
ATHE | $2.33 9.39% 8.58% 170K
|
Health Technology
|
| O: -3.08%
H: 10.32%
C: 0.79%
presentation parkinson ath434 biomarkers
Defence Therapeutics Successfully Engineered and Tested a Novel Intranasal COVID-19 Vaccine Formulation in Animals
Published: 2021-09-20 (Crawled : 15:00) - biospace.com/
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: -3.65%
H: 0.0%
C: 0.0%
covid animals test vaccine defense covid-19
RAPT Therapeutics to Present at the 2021 Cantor Virtual Healthcare Conference
Published: 2021-09-20 (Crawled : 15:00) - globenewswire.com
RAPT | $7.905 -1.19% -1.2% 290K
|
Health Technology
|
| O: -2.51%
H: 1.3%
C: -6.68%
conference
GBT Announces Participation at the Cantor Global Healthcare Conference
Published: 2021-09-20 (Crawled : 15:00) - globenewswire.com
GBT | $68.49 0.02% -0.02%
|
Health Technology
|
| O: -2.57%
H: 2.12%
C: -0.77%
conference
Chinook Therapeutics to Present at Upcoming Investor Conferences
Published: 2021-09-20 (Crawled : 15:00) - globenewswire.com
KDNY | $40.39 0.22% -0.17% 0
|
Health Technology
|
| O: -1.21%
H: 3.18%
C: -1.71%
conference presentation therapeutics
Mirati Therapeutics Announces Long-term Survival Results from an Exploratory Analysis of Sitravatinib plus Nivolumab in Patients with Non-squamous Non-Small Cell Lung Cancer Who are Resistant to Checkpoint Inhibitors
Published: 2021-09-20 (Crawled : 14:15) - biospace.com/
MRTX | $58.7 -0.17% 0.34% 0
|
Health Technology
|
| O: 0.78%
H: 11.36%
C: 3.1%
lung cancer results cancer nivolumab
RAPT Therapeutics to Present RPT193 Phase 1b Data at 30th European Academy of Dermatology and Venereology Congress
Published: 2021-09-20 (Crawled : 14:00) - biospace.com/
RAPT | $7.905 -1.19% -1.2% 290K
|
Health Technology
|
| O: -2.51%
H: 1.3%
C: -6.68%
europe phase 1 phase 1b phase 2b
Medicenna Announces Issuance of U.S. Patent Providing Added Intellectual Property Protection for its MDNA11 ProgramPatent covers the use of IL-2 Superkines such as MDNA11 to treat a wide range of specified cancer types
Published: 2021-09-20 (Crawled : 14:00) - biospace.com/
MDNA | $0.157 -0.32% 1.3M
|
Health Technology
|
| O: -0.8%
H: 1.41%
C: -4.03%
cancer patent
Allogene Therapeutics Adds Renowned CAR T Expert, Jae Park, M.D. to its Scientific Advisory Board
Published: 2021-09-20 (Crawled : 14:00) - biospace.com/
ALLO | $3.04 -9.79% -10.86% 2.1M
|
Health Technology
|
| O: -2.72%
H: 1.94%
C: 0.77%
car-t
Autologous Cell Therapy Market analysis in Pharmaceuticals Industry | $ 4.11 Bn growth expected during 2021-2025 | 17,000+ Technavio Research Reports
Published: 2021-09-20 (Crawled : 13:15) - prnewswire.com
BCLI A | $0.5339 1.7% 1.67% 190K
|
Health Technology
|
| O: -1.13%
H: 0.0%
C: -2.58%
therapy growth research
VYNE Therapeutics to Present at the Cantor Fitzgerald Investment Conference
Published: 2021-09-20 (Crawled : 13:15) - vynetherapeutics.com
VYNE | $2.65 14.22% 12.45% 380K
|
Health Technology
|
| O: -4.46%
H: 2.0%
C: -1.33%
conference presentation therapeutics
Lineage to Present at the 2021 Cantor Virtual Global Healthcare Conference on September 27, 2021
Published: 2021-09-20 (Crawled : 13:15) - biospace.com/
LCTX | $1.1 -3.51% 0.0% 740K
|
Health Technology
|
| O: -5.1%
H: 6.2%
C: -2.89%
conference
Onconova Therapeutics Announces Upcoming Presentation at the 3rd Annual RAS Targeted Drug Development Summit
Published: 2021-09-20 (Crawled : 13:15) - globenewswire.com
ONTX | $0.9953 -5.61% 1.3M
|
Health Technology
|
| O: -4.11%
H: 2.04%
C: -3.67%
presentation drug
Oncternal Therapeutics and Celularity Enter into Research Collaboration to Evaluate Targeted Placental-Derived Cellular Therapies
Published: 2021-09-20 (Crawled : 13:15) - biospace.com/
CELU | News 4 | $3.385 5.45% 5.17% 36K
|
|
| O: 0.0%
H: 1.76%
C: 0.8%
ONCT | $8.755 -0.11% -0.11% 1.6K
|
Health Technology
|
| O: -5.66%
H: 2.5%
C: -1.75%
collaboration research therapy
Celularity and Oncternal Therapeutics Enter into Research Collaboration to Evaluate Targeted Placental-Derived Cellular Therapies
Published: 2021-09-20 (Crawled : 13:15) - biospace.com/
CELU | News 4 | $3.385 5.45% 5.17% 36K
|
|
| O: 0.0%
H: 1.76%
C: 0.8%
ONCT | $8.755 -0.11% -0.11% 1.6K
|
Health Technology
|
| O: -5.66%
H: 2.5%
C: -1.75%
collaboration research therapy
Blade Therapeutics Announces Positive Data from Preclinical Drug-Drug Interaction Study of Cudetaxestat, a Non-Competitive Autotaxin Inhibitor in Clinical Development for Idiopathic Pulmonary Fibrosis (IPF)
Published: 2021-09-20 (Crawled : 13:00) - biospace.com/
GLPG | News | $28.78 -2.28% -2.33% 140K
|
Health Technology
|
| O: -2.97%
H: 2.56%
C: 1.65%
fibrosis positive drug preclinical cudetaxestat pre-clinical
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.